Sublingual immunotherapy (SLIT) trial participants tolerated between 10 and 20 times more peanut protein than it would take for someone to get sick. Researchers say SLIT provides a good cushion of protection with an easy mechanism (tiny bit of liquid under the tongue) and a strong safety signal.
from Latest Science News -- ScienceDaily https://ift.tt/2zOdVBB
via IFTTT
Wednesday, September 4, 2019
New peanut allergy treatment shows effectiveness and safety
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment